The collaborative Takedown effort targeted healthcare fraud that victimizes patients, taxpayers and government programs.
The collaborative Takedown effort targeted healthcare fraud that victimizes patients, taxpayers and government programs.
Collaboration aims to advance both departments' priority enforcement areas by sharing resources in pursuing False Claims Act violations.
Bupa admits to misleading thousands of health insurance customers and unconscionably denying legitimate claims over more than five years.
Whistleblower alleged Caremark reported higher costs of drugs to the government than it paid pharmacies for dispensing Medicare Part D drugs.
Deep dive into the life science and healthcare findings from the CMS GDPR Enforcement Tracker Report 2025.
At the annual pharmaceutical compliance event, panelists said the time for an empowered compliance department engaged in mindful monitoring is now.
Our conversation took in good training programs, the OIG's compliance guidelines, the importance of communication, and more.
Any suggestion of misleading clinical results, false advertising, or bribery to achieve medical approvals would clearly create massive negative publicity.